Clinical Trial Update: The Study on the Efficacy and Safety of Lactobacillus Johnsonii in Combination with CapeOX and Pembrolizumab for the Treatment of MSS/pMMR Metastatic Colorectal Cancer. [NA]

View source ↗

Summary

A clinical trial update describing a study of Lactobacillus Johnsonii with CapeOX and Pembrolizumab for MSS/pMMR metastatic colorectal cancer; the trial is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lactobacillus Johnsonii (Lactobacillus Johnsonii)
• OXALIPLATIN (Oxaliplatin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Metastatic Colorectal Cancer (CRC) | NA | Status: NOT_YET_RECRUITING